Try our Advanced Search for more refined results
KPH Healthcare Services, Inc. v. Mylan N.V. et al
Case Number:
2:20-cv-02065
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Ali & Lockwood
- Hogan Lovells
- Kaufman & Canoles
- Kessler Topaz
- Lathrop GPM
- NastLaw
- Nussbaum Law Group
- Shook Hardy
- Stueve Siegel
- Wagstaff & Cartmell
- White & Case
Companies
Sectors & Industries:
-
July 11, 2024
Pfizer's $50M EpiPen Deal Gets Final OK In Antitrust Suit
Pfizer is officially out of a lawsuit accusing it of working with Mylan Pharmaceuticals to inflate the price of the popular auto-injecting emergency allergy medication EpiPen after a Kansas federal judge gave the $50 million settlement his final seal of approval.
-
October 10, 2023
Pfizer Agrees To Shell Out $50M To Exit EpiPen Antitrust Suit
Pfizer Inc. has agreed to pay $50 million to put to rest allegations it and Mylan Pharmaceuticals conspired to inflate the price of emergency allergy medication, an agreement that wraps up years of litigation and months of negotiations, according to a motion filed in Kansas federal court on Tuesday.
-
August 08, 2022
Judge Trims Pfizer, Mylan EpiPen Antitrust Suit
A federal judge rejected most of the fourth set of antitrust claims alleging that Mylan Pharmaceuticals and Pfizer Inc. conspired to inflate the price of emergency allergy medication, saying that indirect purchasers are barred from filing suit based on the theory that their actions delayed the introduction of a generic.
-
July 26, 2021
Pfizer, Mylan Beat EpiPen Antitrust Suit, For Now
A Kansas federal judge on Monday tossed a lawsuit alleging Mylan Pharmaceuticals and Pfizer Inc. inflated the price of emergency allergy medication EpiPen, saying the pharmacy operator behind the suit doesn't have standing to sue and hasn't shown it's a direct buyer, but he'll allow the operator to redo its claims.
-
December 15, 2020
Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit
Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy operator behind the suit not only failed to show it is a direct purchaser but also failed to state an antitrust claim at all.
-
June 19, 2020
Pharma Co. Must Mediate EpiPen Pricing Claims With Mylan
A retail and online pharmacy operator suing Mylan in Kansas federal court over an alleged scheme to inflate prices for the emergency allergy medication EpiPen has been ordered to mediate its antitrust claims.
-
May 18, 2020
Mylan Pushes For Mediation In EpiPen Antitrust Suit
Mylan has urged a Kansas federal judge to compel a pharmacy operator to mediate its proposed class action over the price of emergency allergy medication EpiPen, saying the company is bound by a contract that requires it to enter mediation before filing a suit.